QQQ   357.09 (+0.69%)
AAPL   184.17 (+1.78%)
MSFT   338.48 (+0.92%)
META   274.83 (+0.81%)
GOOGL   127.19 (+2.02%)
AMZN   125.54 (+1.04%)
TSLA   217.24 (+1.53%)
NVDA   392.29 (-0.25%)
NIO   7.67 (+1.46%)
BABA   83.67 (-0.71%)
AMD   118.99 (+0.96%)
T   15.39 (+1.18%)
F   12.62 (+1.86%)
MU   68.21 (-1.39%)
CGC   0.78 (-5.13%)
GE   104.75 (-0.99%)
DIS   90.47 (-0.33%)
AMC   4.63 (+1.76%)
PFE   38.76 (+1.04%)
PYPL   64.47 (+0.80%)
NFLX   411.40 (+2.73%)
QQQ   357.09 (+0.69%)
AAPL   184.17 (+1.78%)
MSFT   338.48 (+0.92%)
META   274.83 (+0.81%)
GOOGL   127.19 (+2.02%)
AMZN   125.54 (+1.04%)
TSLA   217.24 (+1.53%)
NVDA   392.29 (-0.25%)
NIO   7.67 (+1.46%)
BABA   83.67 (-0.71%)
AMD   118.99 (+0.96%)
T   15.39 (+1.18%)
F   12.62 (+1.86%)
MU   68.21 (-1.39%)
CGC   0.78 (-5.13%)
GE   104.75 (-0.99%)
DIS   90.47 (-0.33%)
AMC   4.63 (+1.76%)
PFE   38.76 (+1.04%)
PYPL   64.47 (+0.80%)
NFLX   411.40 (+2.73%)
QQQ   357.09 (+0.69%)
AAPL   184.17 (+1.78%)
MSFT   338.48 (+0.92%)
META   274.83 (+0.81%)
GOOGL   127.19 (+2.02%)
AMZN   125.54 (+1.04%)
TSLA   217.24 (+1.53%)
NVDA   392.29 (-0.25%)
NIO   7.67 (+1.46%)
BABA   83.67 (-0.71%)
AMD   118.99 (+0.96%)
T   15.39 (+1.18%)
F   12.62 (+1.86%)
MU   68.21 (-1.39%)
CGC   0.78 (-5.13%)
GE   104.75 (-0.99%)
DIS   90.47 (-0.33%)
AMC   4.63 (+1.76%)
PFE   38.76 (+1.04%)
PYPL   64.47 (+0.80%)
NFLX   411.40 (+2.73%)
QQQ   357.09 (+0.69%)
AAPL   184.17 (+1.78%)
MSFT   338.48 (+0.92%)
META   274.83 (+0.81%)
GOOGL   127.19 (+2.02%)
AMZN   125.54 (+1.04%)
TSLA   217.24 (+1.53%)
NVDA   392.29 (-0.25%)
NIO   7.67 (+1.46%)
BABA   83.67 (-0.71%)
AMD   118.99 (+0.96%)
T   15.39 (+1.18%)
F   12.62 (+1.86%)
MU   68.21 (-1.39%)
CGC   0.78 (-5.13%)
GE   104.75 (-0.99%)
DIS   90.47 (-0.33%)
AMC   4.63 (+1.76%)
PFE   38.76 (+1.04%)
PYPL   64.47 (+0.80%)
NFLX   411.40 (+2.73%)
NASDAQ:DMAC

DiaMedica Therapeutics (DMAC) Earnings Date, Estimates & Call Transcripts

$2.60
0.00 (0.00%)
(As of 11:47 AM ET)
Compare
Today's Range
$2.54
▼
$2.68
50-Day Range
$1.53
▼
$2.84
52-Week Range
$1.12
▼
$3.17
Volume
19,150 shs
Average Volume
43,505 shs
Market Capitalization
$68.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Aug. 9Estimated
Actual EPS
(Mar. 28)
-$0.14
Consensus EPS
(Mar. 28)
-$0.14
Last Year's Q1 EPS
(3/14/2022)
-$0.10
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

DMAC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DMAC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

DiaMedica Therapeutics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.16)($0.16)($0.16)
Q2 20231($0.18)($0.18)($0.18)
Q3 20231($0.19)($0.19)($0.19)
Q4 20231($0.19)($0.19)($0.19)
FY 20234($0.72)($0.72)($0.72)

DMAC Earnings Date and Information

DiaMedica Therapeutics last announced its earnings results on March 28th, 2023. The reported ($0.14) earnings per share for the quarter, meeting the consensus estimate of ($0.14). DiaMedica Therapeutics has generated ($0.59) earnings per share over the last year (($0.59) diluted earnings per share). DiaMedica Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 9th, 2023 based off prior year's report dates.

DiaMedica Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/9/2023
(Estimated)		        
3/28/2023Q4 2022($0.14)($0.14)($0.14)    
11/9/2022Q3 2022($0.13)($0.12)+$0.01($0.12)
8/10/2022Q2 2022($0.16)($0.13)+$0.03($0.13)    
5/4/2022Q1 2022($0.20)($0.13)+$0.07($0.13)    
3/14/2022Q4 2021($0.16)($0.10)+$0.06($0.10)    
11/10/20219/30/2021($0.23)($0.18)+$0.05($0.18)    
8/11/20216/30/2021($0.19)($0.17)+$0.02($0.17)    
5/5/20213/31/2021($0.23)($0.19)+$0.04($0.19)  
3/11/202112/31/2020($0.17)($0.23)($0.06)($0.23)  
11/4/20209/30/2020($0.15)($0.19)($0.04)($0.19)  
8/11/20206/30/2020($0.15)($0.1750)($0.0250)($0.17)  
5/13/20203/31/2020($0.28)($0.19)+$0.09($0.19)  
3/23/202012/31/2019($0.25)($0.21)+$0.04($0.21)  
11/13/2019Q3($0.19)($0.20)($0.01)($0.20)  
8/13/2019Q2 2019($0.28)($0.21)+$0.07($0.21)
5/13/20193/31/2019($0.22)($0.27)($0.05)($0.27)
3/19/2019Q4 2018($0.11)($0.11)($0.11)
11/19/2018Q3 2018($0.07)($0.07)($0.07)$0.50 million
8/29/2018Q2 2018($0.20)($0.40)($0.20)($0.20)
8/29/2018Q2 2018($0.01)($0.02)($0.01)($0.01)
5/30/2018Q1 2018($0.20)($0.20)($0.20)












DiaMedica Therapeutics Earnings - Frequently Asked Questions

When is DiaMedica Therapeutics's earnings date?

DiaMedica Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 9th, 2023 based off last year's report dates. Learn more on DMAC's earnings history.

Did DiaMedica Therapeutics beat their earnings estimates last quarter?

In the previous quarter, DiaMedica Therapeutics (NASDAQ:DMAC) reported ($0.14) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.14). Learn more on analysts' earnings estimate vs. DMAC's actual earnings.

How can I listen to DiaMedica Therapeutics's earnings conference call?

The conference call for DiaMedica Therapeutics's latest earnings report can be listened to online. Listen to Conference Call

How can I read DiaMedica Therapeutics's conference call transcript?

The conference call transcript for DiaMedica Therapeutics's latest earnings report can be read online. Read Transcript

How much profit does DiaMedica Therapeutics generate each year?

DiaMedica Therapeutics (NASDAQ:DMAC) has a recorded net income of -$13.68 million. DMAC has generated -$0.59 earnings per share over the last four quarters.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:DMAC) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -